HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Boston Scientific to Pay $716 Mill. to J&J in Legal Settlement

By HospiMedica International staff writers
Posted on 02 Oct 2009
In a multimillion-dollar settlement, Boston Scientific (Natick, MA, USA) has agreed to compensate Johnson & Johnson (J&J; New Brunswick, NJ, USA) over patent claims.

The announced settlement, amounting to US$716 million, substantially resolves Boston Scientific's legal obligation to J&J after 12 years of lawsuits over conflicting patent claims about stents used in interventional cardiology. The settlement resolves 14 lawsuits between the two companies, with possibly 3 more lawsuits remaining unsettled. The settlement also includes patents and cross-licenses between the companies.

Also pending is a court win in which Boston Scientific was favored in a patent verdict against J&J. The amount of the judgment, however, is not known at this time.

Major stent manufacturers, among them Abbott and Medtronic, have filed patent lawsuits against each other, some of which have been settled to date. Earlier in 2009, Boston Scientific has also settled a patent claim lawsuit with Medtronic.

Boston Scientific leads the stent market with $4 billion in annual sales.

Related Links:
Boston Scientific
Johnson and Johnson


Gold Member
12-Channel ECG
CM1200B
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Immobilization System
Cranial 4Pi Immobilization
Resorbable Bovine Collagen Membrane
GenDerm

Channels

Artificial Intelligence

view channel
Image: Coredio’s CPSE is a a software-as-a-medical-device platform designed for use with consumer smartwatches and standard blood pressure cuffs in clinical and home settings under physician supervision (Photo courtesy of Coredio)

AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure

Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more